Hydrophilic polymers -: biocompatibility testing in vitro

被引:39
作者
Kejlová, K
Labsky, J
Jírová, D
Bendová, H
机构
[1] Natl Inst Publ Hlth, Natl Reference Ctr Cosmet, Prague 10042 10, Czech Republic
[2] Acad Sci Czech Republ, Inst Macromol Chem, Prague 15206 6, Czech Republic
关键词
biocompatibility; hydrophilic polymer; 3T3 NRU cytotoxicity test; 3D human skin model; human patch test;
D O I
10.1016/j.tiv.2005.06.032
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Biocompatibility is one of the main prerequisites for safe use of medical devices. Estimation of cytotoxicity is a part of the initial evaluation laid down in ISO standards on biological evaluation of medical devices. Hydrophilic polymers (based on 2-hydroxyethyl methacrylate HEMA) doped by addition of selected additives with antioxiclant and/or free radical scavenging potential (vitamin C and hindered amine stabilizer N-(2,2,6,6-tetramethylpiperidin-4-yl)methacrylamide) were tested in different in vitro systems (3T3 Balb/c cell culture and a 3D human skin model) for biocompatibility and suitability for use as wound dressings. The results of the 3T3 NRU cytotoxicity test using both the direct and indirect contact approaches and a 3D skin model modified irritation test (EpiDerm (TM)) confirmed high biocompatibility and good skin tolerance of both the basic polymers and those enriched with specific additives up to a balanced level. HEMA polymer showed a beneficial effect against cytotoxicity of an irritant (sodium dodecyl sulfate). The in vitro biocompatibility test results were confirmed by human local skin tolerance testing. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:957 / 962
页数:6
相关论文
共 15 条
[1]   THE INHIBITED PHOTO-OXIDATION OF POLYSTYRENE AND STYRENE HALS COPOLYMERS [J].
CHMELA, S ;
HRDLOVIC, P .
POLYMER DEGRADATION AND STABILITY, 1985, 11 (04) :339-348
[2]  
CIOMS WHO, 1993, INT ETH GUID BIOM RE
[3]  
*COLIPA, 1995, EUR COSM TOIL PERF A
[4]  
Groth T, 1995, ATLA-ALTERN LAB ANIM, V23, P790
[5]  
HORAK D, 1992, CHEM LISTY, V86, P681
[6]  
*INT ORG STAND, 1996, BIOL EV MED DEV 12
[7]  
ISO, 1999, BIOL EV MED DEV 5
[8]  
Labsky J., 2003, Patent No. [6610284, US 6610284-B1]
[9]  
LABSKY J, 2003, Patent No. 9928359
[10]  
LABSKY J, 2003, Patent No. 9800046